PROM1 and neoplasm: In breast tumors, Currie et al. firstly associated the expression of CD133 with markers of hypoxia and/or tumor microvasculature in invasive and noninvasive breast carcinoma [23] although most of the further studies correlating CD133 to low oxygen availability were performed in TNBC.